Modulation of the antitumor immune response by complement. - Wikidata - awgldk - TriplyDB

Modulation of the antitumor immune response by complement.

Modulation of the antitumor immune response by complement.

http://www.wikidata.org/entity/Q34838919

about

Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss Myeloid-derived suppressor cells: linking inflammation and cancer Risk of non-Hodgkin lymphoma in association with germline variation in complement genes Beyond CA125: the coming of age of ovarian cancer biomarkers The dual role of complement in cancer and its implication in anti-tumor therapy Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment Complement and macrophage crosstalk during process of angiogenesis in tumor progression Complement in monoclonal antibody therapy of cancer Regulatory myeloid cells in transplantation Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits Structural and functional characterization of human and murine C5a anaphylatoxins Phenotype, development, and biological function of myeloid-derived suppressor cells Myeloid-derived suppressor cells as regulators of the immune system Complement System Part II: Role in Immunity Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish Pre-clinical drug prioritization via prognosis-guided genetic interaction networks A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis Complement: a key system for immune surveillance and homeostasis Integrative analysis to select cancer candidate biomarkers to targeted validation.Mass spectrometry-based secretome analysis of non-small cell lung cancer cell lines.Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Toward predicting metastatic progression of melanoma based on gene expression data.Complement in disease: a defence system turning offensive Role of the complement system in NK cell-mediated antitumor T-cell responses.Cancer and complement.New milestones ahead in complement-targeted therapy.PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition.Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter study.Nanoparticles and the immune system Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.Autocrine effects of tumor-derived complement.

P2860

Q24337286-27FAEE16-6FF3-49AD-AF18-3DD6BEB77E1C Q24594632-9FF9CB8D-B70F-4532-B27E-AD2573613B40 Q24618908-62D41CAB-A515-4398-82DC-D11C411BB831 Q24641811-384BDF06-9EDD-4AE6-AC94-1C92B362D4B6 Q24648778-935D6E9D-98D6-4EBA-9C6D-90D8BE7D7D8C Q24651567-45928A0B-6904-4558-8B09-C35F78CED95B Q26738682-CD265D9E-5432-42E8-B2E8-717AA09967AC Q26745898-C4FE5BCD-FA0A-4A90-B8E7-9D71613A77BD Q26799126-84F5EBE0-982E-4A57-8EB1-7D463070C14E Q26801339-F6B6170B-9CD4-4C50-BC18-AAE6C4C128E9 Q26860800-F49B0145-12FB-4112-9476-686EB5B6CB3C Q26999875-5B6BE371-3E3A-47CB-9B9B-69B65681E4F2 Q27000087-FFD6B2B3-C568-4C00-A51C-DCBBFAD9CC94 Q27012236-1285648B-E478-4992-B576-CCE3F2DF26EB Q27021788-B036B6F7-004A-4835-9987-CBF9645A6557 Q27684270-50E6742A-7551-4DA1-9229-95C7060598BC Q28079046-C63077D2-82AA-450A-B675-272C838BB56E Q28131637-6E513BFB-990C-4467-88D5-81E45D8343A8 Q28263460-C00A1D0A-7ABC-4DDE-BA10-528A734267B7 Q28384476-2A18936D-7A3D-43DC-A8BE-F521CF04A849 Q28393439-91A2CAC8-2F81-4303-A95F-D8789D56D1CA Q28476072-BBF763D1-4F11-49D7-BFEC-7496FD097884 Q28550391-617D9A5E-F630-4C8E-B79D-216731EBF24E Q28748788-BA4698C4-48BC-4772-8DA7-9D16356E2AC7 Q29615484-17162DAB-06B9-4650-826E-BDCC3394718E Q30278389-B4BCDE51-3C2B-4690-92BB-F0DB5EC492C5 Q30313775-4E3FBD01-86BA-42DF-BE86-D4C4E5C8A227 Q30490685-FAB3C150-1131-459D-8437-B8141F9C02F6 Q30924798-B8A9B22E-A51A-4ABB-92AA-46E8829069F5 Q33432423-C106F9DF-B7E3-4C8F-B8AB-8F8BDE17D397 Q33553550-21838915-6B89-4E83-B286-CBF2D7405704 Q33567710-59131507-3179-4676-8E68-D1E541DED436 Q33602320-E6AA883E-86F6-4749-841C-EE6EB709AFAF Q33632044-2AA18B18-67E5-494E-B40F-DA29834C9EA2 Q33633704-088ED176-75B9-4A7B-8300-987C0F65FEFE Q33634320-A8B3AB8B-62FA-4B7C-A41A-0947D297721B Q33707270-B528250C-9E2D-45FB-9B47-BC80330190E8 Q33793485-95DAE6EB-5368-4A73-B37D-0465D6543D70 Q33801802-124F17DF-B4D0-466F-86CB-89679E6AB394 Q33855860-EF140459-DE8B-42EF-9892-73E1B6600AC9

P2860

Modulation of the antitumor immune response by complement.

http://www.wikidata.org/entity/Q34838919

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Modulation of the antitumor immune response by complement.

@ast

Modulation of the antitumor immune response by complement.

@en

Modulation of the antitumor immune response by complement.

@nl

type

label

Modulation of the antitumor immune response by complement.

@ast

Modulation of the antitumor immune response by complement.

@en

Modulation of the antitumor immune response by complement.

@nl

prefLabel

Modulation of the antitumor immune response by complement.

@ast

Modulation of the antitumor immune response by complement.

@en

Modulation of the antitumor immune response by complement.

@nl

P1433

Q34838919-03B65D59-C70B-4266-BCC6-443CA8230D0B

P1476

Q34838919-3EE79D44-39EC-4343-B895-77716E44DBC7

P2093

Q34838919-10217DF4-55D2-4790-BC88-D93A834A5211

Q34838919-12AF7A63-5EF4-496E-9A6F-001F23916E60

Q34838919-A6FDBBAC-376A-4AF3-A7D9-2E85F4B07A0E

Q34838919-AEB2B07A-1F7D-4CE1-907A-1DF787DAD6AC

Q34838919-DAB5CB6F-87DE-4458-AAA4-92FBDA43B308

P2860

Q34838919-055CA1F3-7D70-4195-A42C-29405601D83F

Q34838919-07BDFE2A-92DF-42E3-B7C5-1F79BE7B651E

Q34838919-1ECBF0E4-5A55-4525-B320-8DB97A9CF19C

Q34838919-1ED525A6-4F37-4828-8A7E-B1A0ADFC04ED

Q34838919-2427D5E2-7C5F-4D4B-BAEB-D3DADEA726C3

Q34838919-2AB73524-B5A2-401A-8237-085A1E1FD0A3

Q34838919-362FAFBA-AC7A-4E21-9AB2-FBAD42AB11CB

Q34838919-36941D55-955F-4594-9ECC-AFA71D282A20

Q34838919-3D4AC5BB-BCC7-4A4F-AB6B-4CAD03BA8D79

Q34838919-3DD4C7F1-EBE8-432D-86BB-6880AE1FD14A

P304

Q34838919-AB0BCC41-DFE2-45AE-B433-41837AC078B9

P31

Q34838919-03BBE496-3D31-4A06-A729-31285457700D

P356

Q34838919-BE501752-ADAD-45F3-9FB3-1D1AACA83098

P407

Q34838919-D7A7368F-1A46-4F13-AA45-658D281FF381

P433

Q34838919-234438FD-B609-4D0E-9FDD-BFF97D390670

P478

Q34838919-710F84C6-42E8-402F-BCE7-2F26B8C3FF1B

P50

Q34838919-908E0F31-4407-414D-8B79-19B33758A75A

Q34838919-A1BBDF1E-879A-490D-940B-F562C8FB7F19

Q34838919-A67871E7-C683-4596-96F9-9257DE6B9D95

P577

Q34838919-D7FD2100-276B-401D-959C-61E6DE95437C

P5875

Q34838919-7095C8BF-2A93-4EC7-A360-10409EA9F1FA

P698

Q34838919-1D7F89D3-CFE2-416B-9190-629533FFE132

P932

Q34838919-C96EEBBB-F220-44E5-85C0-7BC0867E25EC

P356

P1433

Nature Immunology

P1476

Modulation of the antitumor immune response by complement.

@en

P2093

Anna Koutoulaki

http://www.w3.org/2001/XMLSchema#string

Craig Gerard

http://www.w3.org/2001/XMLSchema#string

Maciej M Markiewski

http://www.w3.org/2001/XMLSchema#string

Robert A DeAngelis

http://www.w3.org/2001/XMLSchema#string

Salome K Ricklin-Lichtsteiner

http://www.w3.org/2001/XMLSchema#string

P2860

The C5a chemoattractant receptor mediates mucosal defence to infection

Inflammation and cancer

Function, structure and therapeutic potential of complement C5a receptors

Inflammation and cancer: back to Virchow?

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Structure and biology of complement protein C3, a connecting link between innate and acquired immunity

Cancer immunoediting: from immunosurveillance to tumor escape

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines

Abrogation of the alternative complement pathway by targeted deletion of murine factor B

P304

1225-1235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI.1655

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

John D. Lambris

Fabian Benencia

P577

2008-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23286168

http://www.w3.org/2001/XMLSchema#string

P698

18820683

http://www.w3.org/2001/XMLSchema#string

P932

2678913

http://www.w3.org/2001/XMLSchema#string